Victory Capital Management’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-25,718
Closed -$782K 2697
2022
Q3
$782K Buy
+25,718
New +$882K ﹤0.01% 1844
2022
Q1
Sell
-7,319
Closed -$352K 2804
2021
Q4
$352K Buy
7,319
+81
+1% +$4.08K ﹤0.01% 2329
2021
Q3
$402K Sell
7,238
-30
-0.4% -$1.67K ﹤0.01% 2283
2021
Q2
$394K Buy
7,268
+425
+6% +$23.3K ﹤0.01% 2316
2021
Q1
$384K Buy
6,843
+821
+14% +$40.9K ﹤0.01% 2318
2020
Q4
$262K Buy
6,022
+240
+4% +$9.45K ﹤0.01% 2322
2020
Q3
$225K Sell
5,782
-141
-2% -$6.2K ﹤0.01% 2257
2020
Q2
$256K Buy
5,923
+3,922
+196% +$148K ﹤0.01% 2229
2020
Q1
$67K Sell
2,001
-840
-30% -$30.3K ﹤0.01% 2434
2019
Q4
$118K Buy
2,841
+790
+39% +$33.3K ﹤0.01% 2490
2019
Q3
$94K Buy
+2,051
New +$89.4K ﹤0.01% 2458

Other funds holding SRDX

Victory Capital Management's SRDX Position: Q4 2022 in Review

Victory Capital Management sold out of Surmodics (SRDX) in Q4 2022, closing a stake of 25,718 shares — an estimated $782K sold.

Victory Capital Management first reported a position in SRDX in Q3 2019 and held it in 11 quarters. The position peaked at $782K in Q3 2022. 121 funds tracked by Wall St. Rank hold SRDX as of Q4 2022.

  • Victory Capital Management reported no remaining Surmodics position as of Q4 2022 after selling out during the quarter.
  • Victory Capital Management sold 25,718 Surmodics shares in Q4 2022, an estimated $782K.
  • Victory Capital Management first reported a position in Surmodics in Q3 2019 and held it in 11 quarters.
  • Victory Capital Management's Surmodics position peaked at $782K in Q3 2022.
  • 121 funds tracked by Wall St. Rank held Surmodics as of Q4 2022.

Based on Victory Capital Management's 13F filing for Q4 2022, filed 9 Feb 2023.